Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-03-21
1995-04-25
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424435, 424440, 424464, 424468, 424489, 514494, 514777, 514849, 514888, 514889, 514948, 514964, 514965, 514974, A61K 914, A61K 920, A61K 31315, A61K 3330
Patent
active
054099056
ABSTRACT:
Present invention is a non-toxic, flavor stable, pleasant tasting composition releasing Zn.sup.2+ from compositions containing a highly ionizable zinc compound other than zinc gluconate that reduces the duration of common colds in humans. The composition is used in the oral cavity of a human suffering from a common cold. The composition comprises highly ionizable zinc compounds and a pharmaceutically acceptable carrier such as fructose, dextrose or sucrose with various additions. Compositions are unique in that they are non-toxic, pleasant tasting and do not have an offensive aftertaste, yet deliver zinc ions into oral tissues which may be used to treat common colds, reduce the duration of common colds or cure common colds in humans in need of such treatment. Compositions are non-toxic, thermally, chemically and flavor stable. The compositions may be prepared in the form of compressed tablets, lozenges, powders, liquids or chewing gums. Present compositions deliver strongly antirhinoviral and interferon inducing Zn.sup.2+ ions to the oral mucosa of a human. In vitro, Zn.sup.2+ is as antirhinoviral and as protective of cell monolayers as interferon and is also a potent interferon inducer. Said pleasant tasting composition is an improvement upon a slow-release candy composition comprising a hard candy base, highly ionizable zinc compounds and an amino acid; and said composition is an improvement upon a medicinal composition for release of zinc ion consisting essentially of a suitable pharmaceutical carrier, highly ionizable zinc compounds and anethole.
REFERENCES:
patent: Re33465 (1990-11-01), Eby
patent: 3888976 (1975-06-01), Mlkyvy
patent: 4059686 (1977-11-01), Tanaka et al.
patent: 4261982 (1981-04-01), Luedders et al.
patent: 4382924 (1988-05-01), Berling et al.
patent: 4469684 (1984-09-01), Huggins et al.
patent: 4503070 (1985-03-01), Eby
patent: 4684528 (1987-08-01), Godfrey
patent: 4721716 (1988-01-01), Neesby
patent: 4956385 (1990-09-01), Eby
patent: 5002970 (1991-03-01), Eby
patent: 5059416 (1991-10-01), Cherukuri et al.
patent: 5095035 (1992-03-01), Eby
patent: 5286748 (1994-02-01), Eby
Farr et al., Antimicrobial Agents & Chemotherapy, 1987; 31:1183-1187.
Douglas et al., Antimicrobial Agents & Chemotherpay, 1987; 31:1263-1265.
CFR Title 21 .sctn.170.50, Glycine in Food for Human Consumption.
Godfrey et al., The Journal of International Medical Research, 1992; 20:234-246.
Cecchin. Medical World News, 1993 Mar. pp. 30-42.
Eberlein. Redbook Magazine. Dec. 1993:53-56.
Gwaltney. Bottom Line Personal. Mar. 1988:11-12.
B. D. Korant et al., Nature. 1974; 248:588-590.
Korant & Butterworth. Journal of Virology, 1971; 18:298-306.
Butterworth et al., Archives of Virology 1976; 51:169-189.
Korant. Chemical Abstracts 85:76 Abst. No. 814y.
Korant, "Role of Cellular and Viral Protenses in the Processing of Picornavirus Proteins", In: The Molecular Biology of Picornaviruses. 1979:149-173, Perez Bercoff Ed. Plenum Press.
Korant "Inhibition of Viral Proteins Geavage" In: Design of Inhibitors of Viral Functions. Igauri ed. Academic Press.
Merluzzi et al. Research Communications on Chemical Pathology and Pharmacology. 1989; 66:425-440.
Geist et al. Antimicrobial Agents & Chemotherapy. 1987; 31:622-624.
Salas & Kirchner. Clinical Immunology and Immunopathology. 1987; 45:139-142.
Eby et al. Antimicrobial Agents & Chemotherapy. 1984; 25:20-24.
Al-Nakib. Journal of Antimicrobial Chemotherapy. 1987; 20:893-901.
Smith et al. Antimicrobial Agents & Chemotherapy 1989; 33:646-648.
Berthon, May & Williams, Journal of the Chemical Society, Dalton 1978; 1433-1438.
Letter from R. J. E. Williams to R. M. Douglas. Aug. 27, 1987.
Figure from Guy Berthow--Zinc Species in Zine Gluconate-Glycine.
CFR Title 21 Paragraph 170.50 Glycine in Food for Human Consumption.
Pasternak BioAssays 1987; 6:14.
Pasternak, Bioscience Reports. 1987; 7:81-91.
Bashford, et al. J. Bio Chem. 1986; 261:9300.
Bashford, et al., J. Immunol. 1988; 141:3965.
Bashford, et al. J. Membrane Biol. 1988; 103:79.
Chvadil, Med. Clinic North America 1976; 60:799.
Osol A, Remington's Pharmaceutical Sciences, 16 Edition 1980:720.
Eby, "The Zinc and Common Cold Story" In: Guy Berthon Ed. Handbook on Metal Ligand Interaction of Biological Fluids, Marcel Dekker Inc. 1994.
Eby, G. A., Draft Copy of Handbook for Curing the Common Cold (The Zinc Lozenge Story) 1993.
Briggs et al., Carbohydrate Research. 1981; 97:181.
LandOfFree
Cure for commond cold does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cure for commond cold, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cure for commond cold will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1567742